Cargando…

Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability

OBJECTIVES: The optimal tool for identifying depression after stroke is yet to be identified. In the present study, we propose a new context-specific screening tool for PSD and examined its construct validity and reliability within existing data on recent stroke survivors. METHODS: We assessed basel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojagbemi, Akin, Owolabi, Mayowa, Akinyemi, Joshua, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709821/
https://www.ncbi.nlm.nih.gov/pubmed/29202106
http://dx.doi.org/10.1016/j.ensci.2017.10.002
_version_ 1783282845918167040
author Ojagbemi, Akin
Owolabi, Mayowa
Akinyemi, Joshua
Ovbiagele, Bruce
author_facet Ojagbemi, Akin
Owolabi, Mayowa
Akinyemi, Joshua
Ovbiagele, Bruce
author_sort Ojagbemi, Akin
collection PubMed
description OBJECTIVES: The optimal tool for identifying depression after stroke is yet to be identified. In the present study, we propose a new context-specific screening tool for PSD and examined its construct validity and reliability within existing data on recent stroke survivors. METHODS: We assessed baseline data being collected as part of an intervention to improve one-year blood pressure control among recent (≤ one month) stroke survivors. Depression was measured using the Hospital Anxiety and Depression Scale (HADS-D). We also independently administered the 26-items Health Related Quality of Life in Stroke Patients (HRQOLISP-26), a stroke-specific measure developed from a large cross-cultural sample. Using standard protocol, we identified 6 psychoemotional-domain items of the HRQOLISP-26 fitting a single dimensional model with phenomenological and conceptual overlap with the depression framework in the 10th revision of the International Classification of Diseases (ICD-10). We examined construct validity by comparing HRQOLISP-E with the HADS-D, and known group validity by comparing with age, gender, and stroke severity using both the Pearson product moment coefficient and multivariate regression analyses. Internal consistency and split-half reliability were also determined. RESULTS: Each HRQOLISP-E item (r = − 0.40 to − 0.53, all p < 0.001), as well as the total HRQOLISP-E score (− 0.53, p < 0.001) showed significant correlation with the HADS-D. The HRQOLISP-E scores also correlated significantly with age and stroke severity. Depression assessed using the HRQOLIPS-E was independently associated with older age and stroke severity. All HRQOLISP-E items scale correlations were > 0.8 (0.81–0.93) compared with 0.56–0.68 for the HADS-D (Cronbach's alpha = 0.939, versus 0.742 for the HADS-D, Split-half reliability = 0.899, versus 0.739 for HADS-D). CONCLUSION: These results provides preliminary support for further development of the HRQOLISP-E as a context-specific screening tool for PSD through an investigation comparing the proposed measure against a referent-standard clinical diagnostic criteria such as the ICD 10 or Diagnostic and Statistical Manual of Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders.
format Online
Article
Text
id pubmed-5709821
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57098212017-12-01 Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability Ojagbemi, Akin Owolabi, Mayowa Akinyemi, Joshua Ovbiagele, Bruce eNeurologicalSci Original Article OBJECTIVES: The optimal tool for identifying depression after stroke is yet to be identified. In the present study, we propose a new context-specific screening tool for PSD and examined its construct validity and reliability within existing data on recent stroke survivors. METHODS: We assessed baseline data being collected as part of an intervention to improve one-year blood pressure control among recent (≤ one month) stroke survivors. Depression was measured using the Hospital Anxiety and Depression Scale (HADS-D). We also independently administered the 26-items Health Related Quality of Life in Stroke Patients (HRQOLISP-26), a stroke-specific measure developed from a large cross-cultural sample. Using standard protocol, we identified 6 psychoemotional-domain items of the HRQOLISP-26 fitting a single dimensional model with phenomenological and conceptual overlap with the depression framework in the 10th revision of the International Classification of Diseases (ICD-10). We examined construct validity by comparing HRQOLISP-E with the HADS-D, and known group validity by comparing with age, gender, and stroke severity using both the Pearson product moment coefficient and multivariate regression analyses. Internal consistency and split-half reliability were also determined. RESULTS: Each HRQOLISP-E item (r = − 0.40 to − 0.53, all p < 0.001), as well as the total HRQOLISP-E score (− 0.53, p < 0.001) showed significant correlation with the HADS-D. The HRQOLISP-E scores also correlated significantly with age and stroke severity. Depression assessed using the HRQOLIPS-E was independently associated with older age and stroke severity. All HRQOLISP-E items scale correlations were > 0.8 (0.81–0.93) compared with 0.56–0.68 for the HADS-D (Cronbach's alpha = 0.939, versus 0.742 for the HADS-D, Split-half reliability = 0.899, versus 0.739 for HADS-D). CONCLUSION: These results provides preliminary support for further development of the HRQOLISP-E as a context-specific screening tool for PSD through an investigation comparing the proposed measure against a referent-standard clinical diagnostic criteria such as the ICD 10 or Diagnostic and Statistical Manual of Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders. Elsevier 2017-10-31 /pmc/articles/PMC5709821/ /pubmed/29202106 http://dx.doi.org/10.1016/j.ensci.2017.10.002 Text en © 2017 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Ojagbemi, Akin
Owolabi, Mayowa
Akinyemi, Joshua
Ovbiagele, Bruce
Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability
title Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability
title_full Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability
title_fullStr Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability
title_full_unstemmed Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability
title_short Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability
title_sort proposing a new stroke-specific screening tool for depression: examination of construct validity and reliability
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709821/
https://www.ncbi.nlm.nih.gov/pubmed/29202106
http://dx.doi.org/10.1016/j.ensci.2017.10.002
work_keys_str_mv AT ojagbemiakin proposinganewstrokespecificscreeningtoolfordepressionexaminationofconstructvalidityandreliability
AT owolabimayowa proposinganewstrokespecificscreeningtoolfordepressionexaminationofconstructvalidityandreliability
AT akinyemijoshua proposinganewstrokespecificscreeningtoolfordepressionexaminationofconstructvalidityandreliability
AT ovbiagelebruce proposinganewstrokespecificscreeningtoolfordepressionexaminationofconstructvalidityandreliability